Dermira Announces “Life Unfolds” Direct-to-Consumer Campaign to Highlight QBREXZA™ (glycopyrronium) Cloth
March 25, 2019 00:00 ET
|
Dermira, Inc.
New multichannel consumer campaign will feature QBREXZA patientsCampaign to drive consumer awareness of QBREXZAQBREXZA is the first and only FDA-approved, once-daily, topical prescription treatment...
What Happens When Hyperhidrosis Goes to Carnegie Hall?
November 15, 2018 10:57 ET
|
International Hyperhidrosis Society
New Documentary Highlights Professional Flutist’s Struggles with Excessive Sweating CENTER VALLEY, Pa., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Caryn Toriaga is a successful professional flutist in New...
Hyperhidrosis Doesn’t Treat Itself
November 08, 2018 11:44 ET
|
International Hyperhidrosis Society
Raising Awareness Among Healthcare Providers Because, When a Clinician Understands Excessive Sweating, It Makes All the Difference CENTER VALLEY, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Great...
OPEN CALL: #MyHhStory AUDIO Project
November 02, 2018 14:39 ET
|
International Hyperhidrosis Society
Excessive Sweating Story Will Be Selected for Professional Recording & Archived in Library of Congress CENTER VALLEY, Pa., Nov. 02, 2018 (GLOBE NEWSWIRE) -- When someone suffers from...
Dermira and Christian Siriano Collaborate to Inspire People Living with Excessive Underarm Sweating to Feel Confident in Their Own Skin
October 02, 2018 08:30 ET
|
Dermira, Inc.
Mr. Siriano invites the millions of people living with hyperhidrosis in the U.S. to share their ‘sweat stories’ MENLO PARK, Calif., Oct. 02, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a...
Dermira Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 13, 2016 16:05 ET
|
Dermira, Inc.
MENLO PARK, Calif., June 13, 2016 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to identifying, developing and commercializing innovative, differentiated...
Dermira Announces Proposed Public Offering of Common Stock
June 07, 2016 16:06 ET
|
Dermira, Inc.
MENLO PARK, Calif., June 07, 2016 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to identifying, developing and commercializing innovative, differentiated...
Dermira Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Trials for DRM04 in Patients with Primary Axillary Hyperhidrosis
June 01, 2016 16:05 ET
|
Dermira, Inc.
MENLO PARK, Calif., June 01, 2016 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to identifying, developing and commercializing innovative, differentiated...
Dermira Reports First Quarter 2016 Financial Results and Provides Corporate Update
May 10, 2016 06:30 ET
|
Dermira, Inc.
- Positive Topline Results for DRM01 Phase 2b Acne Trial Reported; Phase 3 Program Planning Underway - Announcement of Topline Results for DRM04 Phase 3 Hyperhidrosis Pivotal Trials Expected in...
Dermira Provides DRM01 and DRM04 Development Program Updates
January 07, 2016 16:05 ET
|
Dermira, Inc.
Enrollment Completed in DRM01 Phase 2b Acne Trial; Topline Data Expected in 2Q16 Topline Data for DRM04 Phase 3 Hyperhidrosis Program Expected Mid-2016 MENLO PARK, Calif., Jan. 07, 2016 (GLOBE...